Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters
Monday, June 17, 2013 - 9:17am
tags:
diabetes, Novo Nordisk, Sanofi, Eli Lilly, dulaglutide, Victoza, Lyxumia, Lantus
J&J to Buy Aragon Pharmaceuticals for Cancer Candidate
Bloomberg
Monday, June 17, 2013 - 9:15am
tags:
Aragon, JNJ, M&A, ARN-509, prostate cancer
Biotechs Lose Ground As Achillion Takes a Dive
The Motley Fool
Sunday, June 16, 2013 - 11:33am
tags:
biotech, Achillion, stock
Incyte Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients with Myelofibrosis
Yahoo/BusinessWire
Sunday, June 16, 2013 - 11:33am
tags:
Incyte, clinical trials, Jakafi, myelofibrosis
Abbott Declares Dividend and $3 Billion Buyback Plan
The Motley Fool
Sunday, June 16, 2013 - 11:28am
tags:
Abbott, dividend, stock, stock buyback
Uncle Sam Taps Big Pharma to Combat Antibiotic Resistance
The Motley Fool
Sunday, June 16, 2013 - 11:27am
tags:
government, antibiotic resistance
Another Alzheimer's Disease Failure
The Motley Fool
Sunday, June 16, 2013 - 11:25am
tags:
Alzheimer's disease, Eli Lilly
Is Johnson & Johnson A Buy At These Prices?
Wall Street Cheat Street
Saturday, June 15, 2013 - 1:16pm
tags:
JNJ
Johnson & Johnson's Gut Feeling About the Future of Medicine
Motley Fool
Saturday, June 15, 2013 - 1:14pm
tags:
JNJ, microbiome, Second Genome
Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
NY Times
Saturday, June 15, 2013 - 1:13pm
tags:
Questcor Pharmaceuticals, Synacthen, Novartis, H.P. Acthar Gel
FDA approves new silicone breast implant from J&J
Yahoo/AP
Saturday, June 15, 2013 - 1:12pm
tags:
breast implants, JNJ
New Data on UCB's Cimzia
Yahoo/Zacks
Saturday, June 15, 2013 - 1:11pm
tags:
UCB Pharmaceuticals, Cimzia, psoriatic arthritis, spondyloarthritis
J&J Says It Sells Final Stake in Elan for $332 Million
Bloomberg
Saturday, June 15, 2013 - 1:09pm
tags:
JNJ, Elan
Merck to Cut Research Jobs as Perlmutter Sets Direction
Bloomberg
Saturday, June 15, 2013 - 1:08pm
tags:
Merck, R&D, layoffs
Strong Product Pipelines Have Pharmaceutical Companies Poised for Growth
Motley Fool
Saturday, June 15, 2013 - 1:07pm
tags:
Puma Biotechnology, Pfizer, AstraZeneca
A Trio of Cancer Immunotherapy Innovators
Motley Fool
Saturday, June 15, 2013 - 1:02pm
tags:
Immunogen, Seattle Genetics, Celldex
Elan Is In Play
Seeking Alpha
Saturday, June 15, 2013 - 1:01pm
tags:
Elan, M&A
Elan Inviting Royalty Pharma Bid Shows Hostility Easing
Bloomberg
Saturday, June 15, 2013 - 1:01pm
tags:
Elan, Royalty Pharma, M&A
Amgen Inc (AMGN): Today's Featured Drugs Laggard
The Street
Saturday, June 15, 2013 - 12:59pm
tags:
Amgen
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Laggard
The Street
Saturday, June 15, 2013 - 12:59pm
tags:
Regeneron

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.